<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The growing increase in microorganismal resistance to conventional antimicrobial drugs such as aminoglycosides has been challenging the scientific community and causing serious public health risks [
 <xref rid="B1-antibiotics-08-00028" ref-type="bibr" class="xref">1</xref>]. Aminoglycosides are a class of antibiotics which have been used to treat many bacterial infections, and possess a mechanism of action based on protein synthesis inhibition by binding to the prokaryotic 30S ribosome, preventing adequate mRNA translation [
 <xref rid="B2-antibiotics-08-00028" ref-type="bibr" class="xref">2</xref>,
 <xref rid="B3-antibiotics-08-00028" ref-type="bibr" class="xref">3</xref>].
</p>
